GlassScriptPhysician profile
Cesar Ceballos
NPI 1952366502
$10,010.71
in general payments reported to CMS, 2019-2025
28 companies · $2,120 in 2025
The $2,120 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,003 · 2020: $79.44 · 2021: $356 · 2022: $392 · 2023: $992 · 2024: $3,068 · 2025: $2,120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,505 · Consulting Fee: $2,500 · Travel and Lodging: $1,025 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,505.06 |
| Consulting Fee | $2,500.00 |
| Travel and Lodging | $1,025.24 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $150.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $7,261.07 | 2019-2025 | |
| Miach Orthopaedics, INC. | $677.18 | 2023-2025 | |
| Depuy Synthes Sales INC. | $376.10 | 2020-2024 | Orthovisc, Monovisc, Twistr |
| Zimmer Biomet Holdings, INC. | $267.81 | 2021-2024 | Tricera Handpiece, Accufill |
| Vericel Corporation | $160.05 | 2020-2024 | Maci |
| Biotronik Nro, INC. | $159.56 | 2025 | Prospera |
| Bard Peripheral Vascular, INC. | $159.42 | 2022-2024 | Venclose Maven Catheter |
| Southern Edge Orthopaedics, INC. | $154.37 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $137.48 | 2021-2025 | Exparel |
| Kowa Pharmaceuticals America, INC. | $68.85 | 2022-2023 | Seglentis, Livalo |
| Aroa Biosurgery Incorporated | $66.64 | 2024 | |
| Embody, INC. | $60.08 | 2021 | |
| Stryker Corporation | $55.07 | 2023 | Aequalis Perform Reversed, Blueprint Patient Specific Instrumentation, Aequalis Flex Revive |
| Kci USA, INC. | $37.26 | 2021 | |
| Electronic Waveform Lab, INC. | $37.18 | 2024-2025 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Saluda Medical Americas, INC. | $36.95 | 2025 | Evoke |
| Bioventus LLC | $33.20 | 2023-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Medtronic, INC. | $31.25 | 2024 | Closurefast |
| Abbvie INC. | $29.85 | 2022 | |
| Treace Medical Concepts, INC. | $29.56 | 2023 | |
| Organogenesis INC. | $26.57 | 2024 | |
| Horizon Therapeutics Plc | $24.14 | 2021 | |
| Fidia Pharma USA INC. | $23.39 | 2020 | |
| Smith+Nephew, INC. | $22.72 | 2025 | Renasys Touch, Pico 14 |
| Avanos Medical | $21.64 | 2021 | |
| Pacira Therapeutics, INC. | $20.28 | 2021 | |
| Anika Therapeutics, INC. | $19.23 | 2021 | |
| Curonix LLC | $13.81 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cesar Ceballos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.